Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and $2.53 EPS.
Latest Ratings for ISRG
DateFirmActionFromTo Feb 2022UBSUpgradesNeutralBuy Jan 2022Piper SandlerUpgradesNeutralOverweight Jan 2022Redburn PartnersDowngradesBuyNeutral